Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models

被引:3
|
作者
Kallis, Karoline [1 ]
Mayadev, Jyoti [1 ]
Covele, Brent [1 ]
Brown, Derek [1 ]
Scanderbeg, Daniel [1 ]
Simon, Aaron [1 ]
Frisbie-Firsching, Helena [1 ]
Yashar, Catheryn M. [1 ]
Einck, John P. [1 ]
Mell, Loren K. [1 ]
Moore, Kevin L. [1 ]
Meyers, Sandra M. [1 ]
机构
[1] Univ Calif San Diego, Dept Radiat Med & Appl Sci, San Diego, CA 92103 USA
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
Knowledge-based planning; Dose prediction; Cervical cancer; Intracavitary brachytherapy; Tandem and ovoids; Tandem and ring; HDR-BRACHYTHERAPY; CANCER BRACHYTHERAPY; RADIATION-THERAPY; WORKING GROUP; OPTIMIZATION; TANDEM; ALGORITHM; ANATOMY; QUALITY; RING;
D O I
10.1016/j.brachy.2021.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: Currently, there is a lack of patient-specific tools to guide brachytherapy planning and applicator choice for cervical cancer. The purpose of this study is to evaluate the accuracy of organ-at-risk (OAR) dose predictions using knowledge-based intracavitary models, and the use of these models and clinical data to determine the dosimetric differences of tandem-and-ring (T&R) and tandem-and-ovoids (T&O) applicators. MATERIALS AND METHODS: Knowledge-based models, which predict organ D-2cc, were trained on 77/75 cases and validated on 32/38 for T&R/T&O applicators. Model performance was quantified using Delta D-2cc=D-2cc,D-actual-D-2cc,D-predicted, with standard deviation (sigma(AD(2cc))) representing precision. Model-predicted applicator dose differences were determined by applying T&O models to T&R cases, and vice versa, and compared to clinically-achieved D2cc differences. Applicator differences were assessed using a Student's t-test (p < 0.05 significant). RESULTS: Validation T&O/T&R model precision was 0.65/0.55 Gy, 0.55/0.38 Gy, and 0.43/0.60 Gy for bladder, rectum and sigmoid, respectively, and similar to training. When applying T&O/T&R models to T&R/T&O cases, bladder, rectum and sigmoid D-2cc values in EQD2 were on average 5.69/2.62 Gy, 7.31/6.15 Gy and 3.65/0.69 Gy lower for T&R, with similar HRCTV volume and coverage. Clinical data also showed lower T&R OAR doses, with mean EQD2 D-2cc deviations of 0.61 Gy, 7.96 Gy (p < 0.01) and 5.86 Gy ( p < 0.01) for bladder, rectum and sigmoid. CONCLUSIONS: Accurate knowledge-based dose prediction models were developed for two common intracavitary applicators. These models could be beneficial for standardizing and improving the quality of brachytherapy plans. Both models and clinical data suggest that significant OAR sparing can be achieved with T&R over T&O applicators, particularly for the rectum. (C) 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1323 / 1333
页数:11
相关论文
共 50 条
  • [21] Knowledge-based three-dimensional dose prediction for tandem-and-ovoid brachytherapy
    Cortes, Katherina G.
    Kallis, Karoline
    Simon, Aaron
    Mayadev, Jyoti
    Meyers, Sandra M.
    Moore, Kevin L.
    BRACHYTHERAPY, 2022, 21 (04) : 532 - 542
  • [22] Evaluation of a highly refined prediction model in knowledge-based volumetric modulated arc therapy planning for cervical cancer
    Wang, Mingli
    Gu, Huikuan
    Hu, Jiang
    Liang, Jian
    Xu, Sisi
    Qi, Zhenyu
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [23] Dose Calculation in Gynecological Brachytherapy using Monte Carlo simulation for intracavitary treatment of Cervical Cancer
    Garcia Contreras, O. J.
    Cristancho, F.
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, 2015, VOLS 1 AND 2, 2015, 51 : 452 - 455
  • [24] High-dose-rate brachytherapy using inverse planning optimization with tandem and ovoid applicators for locally advanced cervical cancer: a simulation study
    Yaegashi, Yuji
    Sasaki, Kohei
    RADIOLOGICAL PHYSICS AND TECHNOLOGY, 2021, 14 (03) : 262 - 270
  • [25] Neural network dose models for knowledge-based planning in pancreatic SBRT
    Campbell, Warren G.
    Miften, Moyed
    Olsen, Lindsey
    Stumpf, Priscilla
    Schefter, Tracey
    Goodman, Karyn A.
    Jones, Bernard L.
    MEDICAL PHYSICS, 2017, 44 (12) : 6148 - 6158
  • [26] Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer
    Kirisits, C
    Pötter, R
    Lang, S
    Dimopoulos, J
    Wachter-Gerstner, N
    Georg, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03): : 901 - 911
  • [27] Image-based 3D dosimetric studies with high dose rate intracavitary brachytherapy of cervical cancer
    Chakravarty, N.
    Semwal, M. K.
    Trivedi, G.
    Suhag, V
    Jain, M.
    Sharma, N.
    Vashisth, R. S.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2020, 19 (03) : 277 - 280
  • [28] Megavoltage Computed Tomography Image-based Low-dose Rate Intracavitary Brachytherapy Planning for Cervical Carcinoma
    Wagner, Thomas H.
    Langen, Katja M.
    Meeks, Sanford L.
    Willoughby, Twyla R.
    Zeidan, Omar A.
    Staton, Robert J.
    Shah, Amish P.
    Manon, Rafael R.
    Kupelian, Patrick A.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2009, 8 (02) : 123 - 129
  • [29] VARIABILITY OF MARKER-BASED RECTAL DOSE EVALUATION IN HDR CERVICAL BRACHYTHERAPY
    Wang, Zhou
    Jaggernauth, Wainwright
    Malhotra, Harish K.
    Podgorsak, Matthew B.
    MEDICAL DOSIMETRY, 2010, 35 (04) : 269 - 273
  • [30] Uncertainties in assesment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator
    Berger, Daniel
    Dimopoulos, Johannes
    Georg, Petra
    Georg, Dietmar
    Poetter, Richard
    Kirisits, Christian
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05): : 1451 - 1459